3-D Matrix | Sustainability Performance
Develops self-assembling peptide products including surgical hemostatic agents.
2004
Japan
51 - 200 employees
Medical Device
$25M - 100M in revenue
$1M - 10M in profitability
Sustainability Ranking & Industry Benchmark
#7371
Overall#315
in Japan#110
in Medical DeviceSustainability Maturity
Sustainability Intent
Overview
Governance
TargetsESG scores and exclusionsFinancial Data
Business performanceCapital & innovation
Market cap
Revenue
R&D intensity
Market cap
Revenue
EBITDA
Operating margin
Margin trends
Margin as % of revenue
Gross margin
Operating margin
Net margin
Powered by illuminem
Free cashflow
Capex
Debt/equity ratio
R&D intensity
5.9%FY2026
R&D as % of revenue
R&D as % of revenue
Industry benchmark
Powered by illuminem
Return on invested capital
56.0%FY2026
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Environmental policy coverage
Carbon reduction policy
Not available
Human rights policy
Not available
Recycling policy
Not available
Workplace health & safety policy
Not available
14%
Independent Directors
1 out of 7 incl. management
Overall score
0
Environment
0
Social
0
Governance
0
Exclusion screening
Adult content
Not available
Alcoholic
Not available
Animal testing
Not available
Firearms
Not available
Tobacco
Not available
Gambling
Not available
Nuclear
Not available
Reporting
Not reporting on Sustainability
Not committed to key sustainability initiatives